Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis

Annals of Surgical Oncology

Volumn 15, Issue 6, 2008, Pages 1670-1676

  Kawano, Yuichiro ^a,b   Sasaki, Atsushi ^a,b   Kai, Seiichiro ^b   Endo, Yuichi ^b   Iwaki, Kentaro ^b   Uchida, Hiroki ^b   Shibata, Kohei ^b   Ohta, Masayuki ^b   Kitano, Seigo ^b  

^a Miyazaki Hospital   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Esophageal varices; Hepatic resection; Hepatocellular carcinoma; Liver cirrhosis; Prognosis

Indexed keywords

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ACUTE HEART INFARCTION; ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; DUODENAL ULCER BLEEDING; ENTERITIS; ESOPHAGUS VARICES; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PNEUMONIA; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 43449112642     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9880-7     Document Type: Article

References (21)

1. Sasaki A, Iwashita Y, Shibata K, et al. Improved long-term survival after liver resection for hepatocellular carcinoma in the modern Era: a retrospective study from HCV-endemic areas. World J Surg 2006;30:1567-78
2. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-22
3. Capussotti L, Ferrero A, Viganò L, et al. Portal hypertension: contraindication to liver surgery? World J Surg 2006;30:992-9
4. Bruix J, Sherman M, Llovet JM, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30
5. Minagawa M, Ikai I, Matsuyama Y, et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007;245:909-22
6. Nagasue N, Kohno H, Tachibana M, et al. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg 1999;229:84-90
7. The Liver Cancer Study Group of Japan. Classification of primary liver cancer. 2nd English ed. Tokyo: Kanehara; 2003
8. The Japan Society for Portal Hypertension. The general rules for study of portal hypertension. 2nd ed. Tokyo: Kanehara; 2004, (in Japanese)
9. Kitano S, Iso Y, Hashizume M, et al. Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with Child class A and B liver function: a prospective randomized trial. Hepatology 1992;15:63-8
10. Giannini EG, Russo D, Testa R, et al. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:1378-84
11. Ueno S, Tanabe G, Nuruki K, et al. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg 2002;9:469-77
12. Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years. Ann Surg 1993;217:375-84
13. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198-206
14. Zoli M, Magalotti D, Bianchi G, et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977-85
15. Curley SA, Izzo F, Gallipoli A, et al. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular carcinoma. Ann Surg 1995;222:375-83
16. Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000;47:131-6
17. Mohammed NA, Abd El-Aleem S, Appleton I, et al. Expression of nitric oxide syntase isoforms in human liver cirrhosis. J Pathol 2003;200:647-55
18. Ohta M, Tanoue K, Tarnawski AS, et al. Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology 1997;112:1920-30
19. Le X, Wei D, Huang S, et al. Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci USA 2005;102:8758-63
20. Rahman MA, Dhar DK, Yamaguchi E, et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 2001;7:1325-32
21. Ikeguchi M, Ueta T, Yamane Y, et al. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res 2002;8:3131-6